The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cell proliferation as a biomarker for response to immune checkpoint inhibitors in highly inflamed renal cell carcinoma.
 
Sarabjot Pabla
Employment - OmniSeq
Stock and Other Ownership Interests - OmniSeq
Patents, Royalties, Other Intellectual Property - OmniSeq
 
Jason Zhu
Consulting or Advisory Role - Bayer
Travel, Accommodations, Expenses - UroToday
 
Matthew Labriola
No Relationships to Disclose
 
Rajan Gupta
Honoraria - Bayer Schering Pharma; InvivoCorp
Consulting or Advisory Role - Bard Medical; Bayer Schering Pharma; InvivoCorp
Speakers' Bureau - Bayer Schering Pharma
 
Daniel J. George
Honoraria - Bayer; Exelixis; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Exelixis; Genentech; Innocrin Pharma; Janssen; Merck Sharp & Dohme; Myovant Sciences; Pfizer; Sanofi
Speakers' Bureau - Bayer; Exelixis; Sanofi
Research Funding - Acerta Pharma (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Exelixis (Inst); Innocrin Pharma (Inst); Janssen Oncology (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bayer; Exelixis; Merck; Pfizer; Sanofi
 
Shannon McCall
No Relationships to Disclose
 
Edwin Yau
Stock and Other Ownership Interests - Amgen
Travel, Accommodations, Expenses - Genmab
 
Jeffrey M. Conroy
Employment - OmniSeq
Stock and Other Ownership Interests - OmniSeq
Patents, Royalties, Other Intellectual Property - OmniSeq
 
Sean T. Glenn
Employment - OmniSeq
Stock and Other Ownership Interests - OmniSeq
Patents, Royalties, Other Intellectual Property - OmniSeq
 
Mary Nesline
Employment - OmniSeq
Stock and Other Ownership Interests - OmniSeq
Patents, Royalties, Other Intellectual Property - OmniSeq
 
Antonios Papanicolau-Sengos
Employment - OmniSeq
Stock and Other Ownership Interests - OmniSeq
 
Blake Burgher
Employment - OmniSeq
Stock and Other Ownership Interests - OmniSeq
 
Felicia L. Lenzo
Employment - OmniSeq
Stock and Other Ownership Interests - OmniSeq
 
Tian Zhang
Leadership - Capio BioSciences (I)
Stock and Other Ownership Interests - Capio Biosciences (I)
Honoraria - Exelixis; Genentech/Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Exelixis; Foundation Medicine; Genentech/Roche; Janssen; Pfizer; Pharmacyclics; Sanofi
Speakers' Bureau - Exelixis; Genentech/Roche; Genomic Health; Genzyme
Research Funding - Acerta Pharma (Inst); Janssen (Inst); Merck (Inst); Merrimack (Inst); Novartis (Inst); OmniSeq (Inst); Personal Genome Diagnostics (Inst); Pfizer (Inst); Regeneron (Inst); Stem CentRx (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture by c-MET technology (Inst); Prochelators as Targeted Prodrugs for Prostate Cancer (Inst)
Travel, Accommodations, Expenses - Acerta Pharma
 
Carl Morrison
Employment - OmniSeq
Leadership - OmniSeq
Stock and Other Ownership Interests - OmniSeq
Consulting or Advisory Role - NanoString Technologies
Patents, Royalties, Other Intellectual Property - OmniSeq (Inst)